These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8479750)

  • 1. Tumorigenic activity of rho genes from Aplysia californica.
    Perona R; Esteve P; Jiménez B; Ballestero RP; Ramón y Cajal S; Lacal JC
    Oncogene; 1993 May; 8(5):1285-92. PubMed ID: 8479750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell and tissue-type specific expression of Ras-related GTPase RhoB.
    Fritz G; Gnad R; Kaina B
    Anticancer Res; 1999; 19(3A):1681-8. PubMed ID: 10470101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho proteins induce metastatic properties in vivo.
    del Peso L; Hernández-Alcoceba R; Embade N; Carnero A; Esteve P; Paje C; Lacal JC
    Oncogene; 1997 Dec; 15(25):3047-57. PubMed ID: 9444953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily.
    Jiménez B; Arends M; Esteve P; Perona R; Sánchez R; Ramón y Cajal S; Wyllie A; Lacal JC
    Oncogene; 1995 Mar; 10(5):811-6. PubMed ID: 7898922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.
    Esteve P; del Peso L; Lacal JC
    Oncogene; 1995 Dec; 11(12):2657-65. PubMed ID: 8545123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
    Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GTPases and GTPase regulatory proteins in oncogenesis.
    Grunicke HH; Maly K
    Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
    Saez R; Chan AM; Miki T; Aaronson SA
    Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of Rho in cell transformation by oncogenic Ras.
    Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
    Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
    Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
    Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small GTP-binding proteins of the ras family: a conserved functional mechanism?
    Chardin P
    Cancer Cells; 1991 Apr; 3(4):117-26. PubMed ID: 1909153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene ect2 is related to regulators of small GTP-binding proteins.
    Miki T; Smith CL; Long JE; Eva A; Fleming TP
    Nature; 1993 Apr; 362(6419):462-5. PubMed ID: 8464478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N; Crespo P; Bustelo XR
    Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho small G protein and cytoskeletal control.
    Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
    Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of the RhoB gene from the mouse genome and characterization of its promoter region.
    Nakamura T; Asano M; Shindo-Okada N; Nishimura S; Monden Y
    Biochem Biophys Res Commun; 1996 Sep; 226(3):688-94. PubMed ID: 8831676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway.
    Esteve P; Embade N; Perona R; Jiménez B; del Peso L; León J; Arends M; Miki T; Lacal JC
    Oncogene; 1998 Oct; 17(14):1855-69. PubMed ID: 9778052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
    Jiang K; Delarue FL; Sebti SM
    Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A guide to low molecular weight GTPases.
    Sanders DA
    Cell Growth Differ; 1990 May; 1(5):251-8. PubMed ID: 2150754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.